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ABSTRACT
NECTAR (Non-synonymous Enriched Coding
muTation ARchive; http://nectarmutation.org) is a
database and web application to annotate disease-
related and functionally important amino acids in
human proteins. A number of tools are available to
facilitate the interpretation of DNA variants
identified in diagnostic or research sequencing.
These typically identify previous reports of DNA
variation at a given genomic location, predict its
effects on transcript and protein sequence and
may predict downstream functional consequences.
Previous reports and functional annotations are typ-
ically linked by the genomic location of the variant
observed. NECTAR collates disease-causing
variants and functionally important amino acid
residues from a number of sources. Importantly,
rather than simply linking annotations by a shared
genomic location, NECTAR annotates variants of
interest with details of previously reported variation
affecting the same codon. This provides a much
richer data set for the interpretation of a novel
DNA variant. NECTAR also identifies functionally
equivalent amino acid residues in evolutionarily
related proteins (paralogues) and, where appropri-
ate, transfers annotations between them. As well as
accessing these data through a web interface, users
can upload batches of variants in variant call format
(VCF) for annotation on-the-fly. The database is
freely available to download from the ftp site: ftp://
ftp.nectarmutation.org.
INTRODUCTION
Next-generation sequencing platforms bring a new dimen-
sion to genome research by generating ultrafast and
high-throughput sequencing data on an unprecedented
scale. Important developments including advances in
short-read alignment tools (1,2), variation calling
software (3), target enrichment strategies (4) and the
recent development of desktop-sized sequencing
machines (5) have brought large-scale genome sequencing
within reach of many more researchers. The challenge in
the postgenomic era has therefore shifted from data gen-
eration to data interpretation, and, in particular, to
linking genotype with phenotype.
Non-synonymous single nucleotide variants, which
cause single amino acid substitutions, are a particular
challenge: though most disease-associated variants are
non-synonymous SNPs (6), most non-synonymous SNPs
are common and appear to be functionally neutral (7).
Therefore interpreting the functional importance of
novel SNPs is challenging. The majority (54%) of
known disease-causing mutations in the Human Gene
Mutation Database (HGMD) (8) are missense or
nonsense, followed by deletions and splice site variants,
which account for 16 and 9%, respectively (see Figure 1).
The same amino acid substitution can be generated by
more than one DNA variant because multiple codons
encode a single amino acid (codon degeneracy). For
instance, variants in the myosin regulatory light chain
(MYL2) including c.52T>C (p.Phe18Leu) have been
reported to cause familial hypertrophic cardiomyopathy
(9). Three alleles at two distinct genomic locations could
equally substitute phenylalanine to leucine (c.54C>G,
c.54C>A and c.52T>C), although only one of them
(c.52T>C) has been previously reported. Other alleles
can also substitute this conserved phenylalanine to isoleu-
cine (c.52T>A), valine (c.52T>G), tyrosine (c.53T>A),
cysteine (c.53T>G) or serine (c.53T>C). Therefore the
phenotype associated with c.52C>T may be relevant in
interpreting other alternative missense variants affecting
the same codon. There are publicly (or commercially)
available databases, which catalogue disease-related
variants based on published literature or their own experi-
ments. For example, the Human Genome Variation
Society (HGVS) maintains a website (http://www.hgvs.
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org/dblist/dblist.html) listing Locus-Speciﬁc Databases
and other disease-related variant databases. However,
existing databases based on genomic position do not
readily link reported variants to all alternative alleles af-
fecting the same amino acid residue.
Here we introduce NECTAR (Non-synonymous
Enriched Coding muTation ARchive), which is a
database of non-synonymous variants responsible for
disease and altered protein function. NECTAR aids inter-
pretation of missense variants by giving access to existing
annotations in two new ways: ﬁrst, by cross-linking anno-
tations at the relevant codon level and, secondly, by
transferring annotations between evolutionarily related
proteins. Known disease variants are compiled from
publicly available databases and expanded to archive
possible alternative non-synonymous alleles at the same
codons where the original variants are located.
NECTAR also archives possible non-synonymous
variants that substitute other functionally annotated
amino acid residues. The locations of disease variants
and functional residues are propagated across protein
paralogues, which enables interrogation at the equiva-
lent positions. NECTAR accepts genetic variants in a
variant call format (VCF) ﬁle (10), then annotates them
on-the-ﬂy. NECTAR is freely available to download via
the web (http://nectarmutation.org) and an FTP site
(ftp://ftp.nectarmutation.org) where a simple shell
script is provided for those who wish to mirror the data
locally.
DATA COLLECTION AND ANNOTATION
Compiling external resources
Figure 2 explains the data collection and annotation
pipeline of NECTAR. Non-synonymous disease variants
are collated from the Ensembl variation database (11,12)
and UniProt human polymorphisms and disease variants
(http://www.uniprot.org/docs/humsavar) (13,14). Among
the Ensembl variants, only those from (i) Catalogue of
Somatic Mutation in Cancer (COSMIC) (15), (ii) patho-
genic or probable-pathogenic variants from ClinVar
(http://www.ncbi.nlm.nih.gov/clinvar) or (iii) HGMD-
public (8) resources were used; their genomic positions
were mapped later to their corresponding Ensembl
proteins via canonical transcripts (12,16). UniProt
variants, of which only disease variants were used, were
transferred to their corresponding Ensembl proteins using
bl2seq, a pair-wise alignment software tool, of the NCBI-
BLAST software package (17). For the deﬁnitions of func-
tional amino acid residues, 12 categories of function an-
notations were chosen from UniProt and their positions
were mapped to their corresponding Ensembl human
proteins. Table 1 and Table 2 list the external data
sources and the number of disease variants and functional
amino acids used in NECTAR. To remain up-to-date,
NECTAR aims to update dependent data sets as each
new Ensembl version is released.
Figure 2. A schematic diagram of NECTAR framework. The Ensembl
databases (Core, Variation and Compara) were downloaded and locally
mirrored to speed up database queries using their API. UniProt XML
ﬁles were also mirrored and parsed to construct an equivalent in-house
SQL version. MySQL was used for the main back-end database man-
agement system and Perl for data processing. See the main text for the
description of the workﬂow.
Figure 1. The proportion of HGMD records by their variant types. The
data are drawn from the HGMD professional (version 2013.1) where
disease-causing mutations are tagged as either ‘DM’ or ‘DM?’, which
is deﬁned as ‘pathological mutations reported to be disease causing in
the original literature report’. The question mark denotes that a degree of
doubt has been found to exist with regard to pathogenicity.
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Enriching annotations
NECTAR compiles possible putative missense variants
based on known disease variants and functional amino
acids as described above. There are three classes of
‘NECTAR variant’: (i) known disease-related variants
and possible alternative missense alleles affecting the same
codon, (ii) putative non-synonymous variants substituting
functional amino acid residues, (iii) variants annotated by
sequence homology (paralogue annotations). The amino
acid positions of disease variants and functional residues
were transferred and marked to their equivalent positions
of their paralogues using the gene paralogy deﬁnition
adopted from the EnsemblCompara GeneTree (18). They
are annotated as ‘Para-disease’ and ‘Para-function’ as
shown in Figure 2. Using the TranscriptMapper object of
the Ensembl core Application Programming Interface
(API), the amino acid positions of disease variants, func-
tional residues and their paralogue annotations were
further mapped onto the codon positions of their corres-
ponding Ensembl canonical transcripts. Possible alternative
codons were generated by replacing the ﬁrst, second and
third base of the original codon one-by-one and retained
those that were non-synonymous. In addition to paralogue
annotations, NECTAR provides possible missense variants
for manually curated UniProt disease and function anno-
tations that are only reported at amino acid residue level
through the UniProt website. The functional effects of
NECTAR variants were estimated by SIFT (19) and
PolyPhen (20), which are pre-computed by the Variant
Effect Predictor (VEP) (21) as part of the Ensembl vari-
ation API (11,22).
Table 2. Twelve functional annotations from UniProt and the number possible non-synonymous variants in NECTAR
Category of function Number
of genes
UniProta NECTAR
Abbreviation description Number of
amino acidsb
Number of
possible amino
acid substitutionsb
Number of
DNA variants
CA_BIND Position(s) of calcium binding region(s) within the
protein
230 6075 38 937 43 994
ZN_FING Position(s) and type(s) of zinc ﬁngers within the
protein
1687 241 415 1 539 638 1 745 301
DNA_BIND Position and type of a DNA-binding domain 563 47 152 295 359 332 300
NP_BIND Nucleotide phosphate binding region 1618 28 124 10 560 190 097
ACT_SITE Amino acid(s) directly involved in the activity of an
enzyme
1987 3318 22 704 25 911
METAL Binding site for a metal ion 1239 5775 39 794 45 463
BINDING Binding site for any chemical group (coenzyme, pros-
thetic group, etc.)
1584 4375 28 249 32 042
MOD_RES Modiﬁed residues excluding lipids, glycans and
protein cross-links
6954 32 530 195 862 224 744
LIPID Covalently attached lipid group(s) 614 908 5996 6804
CARBOHYD Covalently attached glycan group(s) 4152 16 622 115 143 131 637
DISULFID Cysteine residues participating in disulﬁde bonds 2894 32 371 226 586 258 954
CROSSLNK Residues participating in covalent linkage(s) between
proteins
445 955 6639 7593
aVersion 2013_08.
bThis number is based on the equivalent Ensembl proteins translated from the Ensembl canonical transcripts.
Table 1. The source of disease variants and the number of variations in NECTAR
Sources of
variants
Number
of genes
From the source NECTAR
Number of amino
acid substitutionsa
Number of alternative
amino acid substitutionsa
Number of
DNA variants
UniProtb 1918 24 730 106 449 145 001
COSMICc 16 794 448 637 2 138 093 2 862 016
HGMD-publicc 2826 Not available 231 504 315 024
ClinVarc 1969 11 724 56 257 74 131
aThis number is based on the Ensembl proteins translated from the Ensembl canonical transcripts.
bVersion 2013_08.
cAs a part of Ensembl variation database version 73.
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FEATURES OF NECTAR
NECTAR is searchable by gene name (HUGO
Gene Nomenclature Committee identiﬁer) or disease
name, which then lists known disease-associated genes.
The web search is enhanced with the Google Custom
Search to facilitate retrieving specialized information in
NECTAR. There are four subsections for each gene
page: (i) disease associations, (ii) disease variants, (iii)
function annotations and (iv) paralogue annotations.
Each variant table is accompanied with a visualization
of the variant positions [Gbrowse (23)] with functional
and protein domain annotations (see Figure 3).
NECTAR variants, accessed via the web interface, are
provided at the amino acid residue level referenced to
the protein translated from the Ensembl canonical
transcript (12,16). Each table is also accompanied by
FTP links for direct download (see Figure 3C). Each sub-
section is further explained below except the disease asso-
ciation section, which is from the UniProt general
annotation section. NECTAR has been tested on
following major web browsers: Internet Explorer 8 and
9, Firefox 3.6.26, 22.0 and 24.0, Chrome 30.0 and Safari
on iOS7.
Disease variants
Table 1 lists the sources of disease variants used in
NECTAR and compares the number of variants
reported from the source and that of possible alternatives
identiﬁed in NECTAR. For example, UniProt reports
24 730 amino acid substitutions responsible for diseases.
From the same source, NECTAR identiﬁes additional
106 449 alternative substitutions at the reported codon
positions by substituting ﬁrst, second or third bases of
the original codons (see Figure 2 for details); all in all,
145 001 variants are available for alternative substitutions
together with the original reports from UniProt.
NECTAR identiﬁes similar fold of increase in the
number of alterative substitutions from COSMIC and
ClinVar.
Figure 3. Screen captures of the NECTAR website. (A) A GBrowse image shows the locations of disease-related amino acid substitutions and a
Pfam domain (coloured in blue bar) along the sequence of MYL2 protein. A ﬁne control of GBrowse image is possible if the image is being clicked.
(B) One possible nonsense and seven missense variants are displayed at the Glu22 of MYL2 protein where Glu22Lys is originally reported by
UniProt (VAR_004603). Their functional effects, predicted by SIFT and PolyPhen, are also shown. (C) Paralogue annotations of TPM4 are
displayed. FTP links are coloured in red on the upper right corner. (D) NECTAR annotations are made on-the-ﬂy from a user-provided VCF
input. A variant is coloured in yellow because it makes the same amino acid substitutions as reported from the source (VAR_019844 from UniProt).
The results can be downloaded as a spread sheet. The input was from http://nectarmutation.org/main/static/nectar_dummy.vcf.
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Function annotations
UniProt provides the most comprehensive catalogue of
protein sequences and function annotations (http://www.
uniprot.org/manual/sequence_annotation), which
describe regions or sites of interest in the protein
sequence. NECTAR archives amino acids annotated as
functional residues by UniProt and extends to compile
possible alternative amino acids at the functional positions
together with the genetic variants responsible for the
amino acid changes. Table 2 shows 12 functional annota-
tions used in NECTAR and the number of reported
amino acids relevant to the functional categories and the
number of possible amino acid replacements identiﬁed by
NECTAR. Like disease variants, the effects of NECTAR
functional variants are predicted by the SIFT and the
PolyPhen—they are presented either from the NECTAR
website if users click the position of the relevant functional
residues, or as a FTP link for a batch download from the
NECTAR gene page where user queried (see Figure 3).
Paralogue annotations
Proteins of shared ancestry may exhibit analogous func-
tions, mediated by conserved sequence motifs or 3D struc-
tures (24,25). Therefore, it is equally interesting to
investigate the effect of non-synonymous variants at the
equivalent amino acid positions between close homo-
logues. Sequence homology information is used to
annotate uncharacterized genes and proteins (26–29) and
for the analysis of non-synonymous SNPs and their
relation to disease (30). Recently, we described an
approach using paralogue annotations for the functional
annotation of non-synonymous variants, ﬁrst validated in
inherited cardiovascular disease (31). A similar approach
was adopted in NECTAR to facilitate propagation of
disease and function information to uncharacterized
proteins. For example, TPM4 (tropomyosin alpha-4
chain), one of four tropomyosin genes, shares >80%
protein sequence identity with its paralogues (TPM1,
TPM2, and TPM3). There are no reported disease
variants for TPM4, at the moment of this writing, either
from HGMD-public or UniProt, whereas its paralogue
TPM1 is reported to be responsible for familial hyper-
trophic cardiomyopathy type 3 (MIM:115196) and cardio-
myopathy dilated type 1Y (MIM:611878); TPM2 for
nemaline myopathy type 4 (MIM:609285) and distal
arthrogryposis type 1A (MIM:108120); TPM3 for
nemaline myopathy type 1 (MIM:609284) and thyroid
papillary carcinoma (MIM:188550). NECTAR annotates
48 amino acids of TPM4 protein where their equivalent
alignment positions are annotated as disease-related either
by HGMD-public, ClinVar or UniProt from its
paralogues (see Figure 3C).
Annotation on-the-ﬂy
When assessing putative disease-causing variants, e.g. for
clinical diagnostics, the ﬁrst step is to consult databases of
known disease variants [e.g. ClinVar, HGMD, T1Dbase
and Locus-Speciﬁc Databases (http://www.hgvs.org/
dblist/glsdb.html)] or public variation data (e.g. dbSNP,
COSMIC and SwissVar) to see whether the observed
variants have been previously reported and characterized.
NECTAR users can upload their variations formatted in a
VCF ﬁle (10) to have them annotated on-the-ﬂy. This
looks up NECTAR variants and annotates non-synonym-
ous variants, if any, from the user input in the three an-
notation sections (disease, function and paralogue) (see
Figure 3D). For those wish to use the Ensembl VEP
(21), which predicts the functional consequences of
genomic variants, NECTAR runs this locally and
provides a link, as shown in Figure 3D, where users can
download the result as a spreadsheet. This provides a
useful complement to NECTAR, which only annotates
missense variants at the moment; the VEP will miss
NECTAR annotations instead, if there are any. The
online Supporting Information explains technical details
of the NECAR web and FTP site including implementa-
tion of the local VEP.
RELATED WORKS
While we are not aware of any web application providing
ready access to the range of codon-centric annotations
compiled in NECTAR, there are other databases and
web servers that could be jointly used to compile annota-
tions equivalent to those provided in NECTAR.
A VEP plug-in (https://github.com/ensembl-variation/
VEP_plugins) is available that looks for existing variants
affecting the same codons as a list of user-provided
variants. Also, UCSC Variant Annotation Integrator
(http://genome.ucsc.edu/cgi-bin/hgVai), ANNOVAR
(32), variant tools (33) and KGGSeq (34) provide a func-
tional prediction and annotation for user provided
variants using dbNSFP (35), which is a database of all
potential non-synonymous single-nucleotide variants in
the human genome. The dbNSFP provides functional pre-
diction scores and conservation scores, which are pre-
computed using a number of tools. Also Whole Human
Exome Sequence Space (ftp://genetics.bwh.harvard.edu/
pph2/whess) archives all putative single-nucleotide non-
synonymous (missense) codon changes and provides an-
notations of pre-computed set of PolyPhen-2 predictions.
However, even though it is possible to have codon-centrc
annotations with additional efforts (e.g. programming for
customized annotations), some of them fail to provide
cross-references for known disease variants and UniProt
function annotations at the codon level. None of the other
web servers/databases provides equivalent sequence pos-
itions across paralogous proteins, although this informa-
tion can be extracted from alternative sources [e.g.
Ensembl Compara (18), UCSC Genome Browser MultiZ
alignments (36) and eggNOG (37)].
DISCUSSION
NECTAR allows data mining of genetic variants not only
from known disease and function annotations, but also
from alternative amino acids (and their responsible
genetic alleles) shared at the same codons where current
annotations are available, further enhanced to facilitate
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the transfer of annotations between equivalent residues
across protein paralogues. The phenotypic consequences
of NECTAR variants can be inferred from linked reports.
NECTAR provides access to publically available data that
may be usefully applied in both diagnostic and research
settings, but these phenotype data are not curated. Users
considering a clinical diagnostic application should be
sure to independently evaluate the quality of the source
data. Also there are a few things to consider when using
NECTAR. NECTAR only covers single base substitu-
tions in protein coding regions. As shown in Figure 1,
45% of disease-causing variants are not single base sub-
stitutions; NECTAR does not evaluate other variant
classes such as radical frame shifts and essential splice
site variants. Recent study reveals most somatic mutations
have little or no implication for cancer development, with
only smaller numbers drive tumour (38); they are not dis-
tinguished in NECTAR for mutations from the COSMIC
database (15).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [39].
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